Leyden J., Stephens T., Finkey M., Barkovic S
In our previous work on combination treatment with an SGLT2 inhibitor and GLP1-RA, we found some baseline characteristics that might identify responders, and relatively low BMI and low insulin secretion were associated with greater bodyweight loss [73]
1 October 2024
Comparative Metabolic Research: Retatrutide is increasingly used in comparative studies examining how triple-receptor agonism differs from dual-receptor and single-receptor approaches
Certain GLP-1 medications are covered by the RAMQ for the treatment of type 2 diabetes, under certain conditions
They include: Anemia (fatigue, pale skin color, lightheadedness, and shortness of breath) Acid build up (metabolic acidosis) Frequent infections Seizures Intellectual disability (speech delay in children) Ataxia symptoms like loss of coordination Stiff muscles (spasticity) Retinal dystrophy What conditions does Glutathione treat